title: Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells.
authors: Chiara
authors: C
authors: Laezza
authors: Alba
authors: A
authors: d'Alessandro
authors: Anna Maria
authors: AM
authors: Malfitano
authors: Maurizio
authors: M
authors: Bifulco
mesh_terms: D001095:Arachidonic Acids / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology; D063386:Cannabinoid Receptor Agonists / Q000494:pharmacology; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D063388:Endocannabinoids / Q000494:pharmacology*; D058750:Epithelial-Mesenchymal Transition / Q000187:drug effects; D005260:Female; D006801:Humans; D053284:Polyunsaturated Alkamides / Q000494:pharmacology*; D060449:Wnt Signaling Pathway / Q000187:drug effects*; D051176:beta Catenin / Q000378:metabolism
chemical_list: D001095:Arachidonic Acids; D063386:Cannabinoid Receptor Agonists; D063388:Endocannabinoids; D053284:Polyunsaturated Alkamides; D051176:beta Catenin; C078814:anandamide